Clinical Kidney Journal

Article	Citations
An introduction to inverse probability of treatment weighting in observational research	298
Conducting correlation analysis: important limitations and pitfalls	76
The ERA Registry Annual Report 2019: summary and age comparisons	64
RICORS2040: the need for collaborative research in chronic kidney disease	51
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis	48
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	46
Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019	39
Fiber intake and health in people with chronic kidney disease	38
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics	37
Epidemiology and burden of chronic kidney disease-associated pruritus	35
Oxalate nephropathy: a review	33
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors	32
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects	31
Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study	30
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease	30
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care	30
The ERA Registry Annual Report 2020: a summary	28
Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine	27
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose	27
Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches	26
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies	26
Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant	24
Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls	24
Albumin is an interface between blood plasma and cell membrane, and not just a sponge	23
Unravelling the pathophysiology of chronic kidney disease-associated pruritus	23

Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4	22
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination	21
Acute kidney injury in COVID-19: multicentre prospective analysis of registry data	21
The Latin American Dialysis and Renal Transplantation Registry: report 2019	21
Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation	21
De novo and relapsing necrotizing vasculitis after COVID-19 vaccination	21
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice	20
Hypophosphatemia in cancer patients	20
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure	20
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis	19
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	19
Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation	19
Comparison of four medium cut-off dialyzers	19
Immune abnormalities in IgA nephropathy	19
The Many Faces of NELL1 MN	19
The kidney in hantavirus infection—epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management	18
Tirzepatide and prevention of chronic kidney disease	18
The rapid development of a novel kidney-specific digital intervention for self-management of physical activity and emotional well-being during the COVID-19 pandemic and beyond: Kidney Beam	18
Primary hyperoxaluria type 1: pathophysiology and genetics	18
Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients	18
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination	17
Point-of-care testing technologies for the home in chronic kidney disease: a narrative review	17
Multitargeted interventions to reduce dialysis-induced systemic stress	17
Burnout and long COVID among the UK nephrology workforce: results from a national survey investigating the impact of COVID-19 on working lives	17
Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study	17
New and old GFR equations: a European perspective	17
Future landscape for the management of membranous nephropathy	17
Primary hyperoxaluria type 1: novel therapies at a glance	16
Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study	16
Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients	16
Blood pressure targets in CKD 2021: the never-ending guidelines debacle	16
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis	16
Correlations, agreement and utility of frailty instruments in prevalent haemodialysis patients: baseline cohort data from the FITNESS study	16
Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study	16
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art	16
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence	15
Early and late acute kidney injury: temporal profile in the critically ill pediatric patient	15
Decreasing microbiota-derived uremic toxins to improve CKD outcomes	15
Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab	15
Nicotinamide and acute kidney injury	15
More on the invisibility of chronic kidney disease… and counting	15
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation	15
Shared decision making: a personal view from two kidney doctors and a patient	15
Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients	15
Treatment of primary hyperoxaluria type 1	14
Management of fracture risk in CKD—traditional and novel approaches	14
Ageing meets kidney disease	14
Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination	14
Association of leukocyte telomere length with chronic kidney disease in East Asians with type 2 diabetes: a Mendelian randomization study	14
Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria	14

Frailty among chronic kidney disease patients on the kidney transplant waiting list: the sex–frailty paradox	14
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	14
Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study	14
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	14
The utility of remote patient management in peritoneal dialysis	14
Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy	14
Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved	13
Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification	13
PoCUS in nephrology: a new tool to improve our diagnostic skills	13
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	13
Peritoneal dialysis–first initiative in India: a cost-effectiveness analysis	13
Robot-assisted kidney transplantation: an update	13
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study	12
New aspects in cardiorenal syndrome and HFpEF	12
The ERA Registry Annual Report 2021: a summary	12
ANCA-associated vasculitis flare might be provoked by COVID-19 infection: a case report and a review of the literature	12
Adult-onset nephrotic syndrome following coronavirus disease vaccination	12
Outcomes and predictors of skin sodium concentration in dialysis patients	12
Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease	12
Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction	12
The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review	12
Development and internal validation of a Wasp Sting Severity Score to assess severity and indicate blood purification in persons with Asian wasp stings	12
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study	12
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study	12
Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics	11
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	11
Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis	11
Randomized comparison of three high-flux dialyzers during high-volume online hemodiafiltration—the comPERFORM study	11
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients	11
The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy	11
Deprivation and chronic kidney disease—a review of the evidence	11
Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines	11
Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach	11
Long-term impact of COVID-19 among maintenance haemodialysis patients	11
Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker	11
Contemporary outcomes of anemia in US patients with chronic kidney disease	11
Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study	11
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Associatio	11
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?	10
Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis	10
The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years	10
Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease	10
Achieving consensus on psychosocial and physical rehabilitation management for people living with kidney disease	10
Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine	10
Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine	10
Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases	10
Digital health interventions in chronic kidney disease: levelling the playing field?	10
Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor	10
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy	10
Incidence of anti-glomerular basement membrane disease during the COVID-19 pandemic	10
Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data	10
Application of the Clinical Frailty Score and body composition and upper arm strength in haemodialysis patients	10
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort	9
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia	9
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury	9
Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care	9
Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease	9
Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes	9
An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits	9
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis	9
Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?	9
Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications	9
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease	9
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy	9
Influence of doctors’ perception on the diagnostic status of chronic kidney disease: results from 976 409 individuals with electronic health records in China	9
Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials	9
Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patients	9
The scientific principles and technological determinants of haemodialysis membranes	9
Stability and compatibility of antibiotics in peritoneal dialysis solutions	9
Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999–2018 National Health and Nutrition Examination Survey	9
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	9
Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease	9
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	9
Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?	9
A roadmap to parathyroidectomy for kidney transplant candidates	9
Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?	9
Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events	9
Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)	9
Acute interstitial nephritis following SARS-CoV-2 vaccination	9
Acute interstitial nephritis after messenger RNA-based vaccination	8

Pseudo-acute kidney injury secondary to tepotinib	8
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression	8
2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis	8
The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait	8
Increased mortality after kidney transplantation in mildly frail recipients	8
Development and validation of a new equation based on plasma creatinine and muscle mass assessed by CT scan to estimate glomerular filtration rate: a cross-sectional study	8
Impact of contrast-induced acute kidney injury on long-term major adverse cardiovascular events and kidney function after percutaneous coronary intervention: insights from a territory-wide cohort stud	8
Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease	8
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	8
Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination	8
Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease	8
Thiazide diuretics are back in CKD: the case of chlorthalidone	8
Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease	8
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review	8
The tryptophan pathway and nicotinamide supplementation in ischaemic acute kidney injury	8
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	8
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patient	8
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact	8
Comparative efficacy of patiromer and sodium polystyrene sulfonate on potassium levels in chronic haemodialysis patients: a randomized crossover trial	8
Semaglutide for treatment of obesity in hemodialysis patients waiting for a kidney transplant: new hope?	8
Novel strategies in nephrology: what to expect from the future?	8
Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort	8
Local anesthetics for the Nephrologist	8
The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis	8
Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms	8
The misuse of funnel plots in meta-analyses of proportions: are they really useful?	8
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction	8
Treatment of acute kidney injury in cancer patients	8
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	8
Early aging and premature vascular aging in chronic kidney disease	8
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease	8
Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis	8
Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort study	8
War in Ukraine and dialysis treatment: human suffering and organizational challenges	8
Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs	8
A functional TGFB1 polymorphism in the donor associates with long-term graft survival after kidney transplantation	8
Expanded hemodialysis: what’s up, Doc?	8
Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain	8
Anaplastic lymphoma kinase inhibitors and their effect on the kidney	8
Increased LDL-cholesterol level is associated with deterioration of renal function in males	8
First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2	7
Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D	7
Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin	7
Peritoneal catheter insertion: combating barriers through policy change	7
Outcomes of patients with COVID-19 on kidney replacement therapy: a comparison among modalities in England	7
Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function	7
All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality	7
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry	7
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	7
Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D	7
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term	7
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	7
Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis	7
Higher ambient nitrogen dioxide is associated with an elevated risk of hospital-acquired acute kidney injury	7
Disparities in treatment and outcome of kidney replacement therapy in children with comorbidities: an ESPN/ERA Registry study	7
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients	7
Primary hyperoxaluria: the pediatric nephrologist's point of view	7
Longitudinal relationship between long sleep duration and future kidney function decline	7
The association of glucose metabolism and kidney function in middle-aged adults	7
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?	7
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't	7
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group	7
Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review	7
Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?	7
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients	7
Targeting complement in IgA nephropathy	7
Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability	6
National survey on genetic test prescription in French adult nephrologists: a call for simplification and education	6
Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment	6
Serum bilirubin and kidney function: a Mendelian randomization study	6
The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis	6
Epidemiology of childhood acute kidney injury in England using e-alerts	6
Decision aids to assist patients and professionals in choosing the right treatment for kidney failure	6
Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome	6
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease	6
Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?	6
COVID-19 vaccination precipitatingde novoANCA-associated vasculitis: clinical implications	6
Probiotics for kidney disease	6
Frailty assessment as part of transplant listing: yes, no or maybe?	6
Management of acute renal replacement therapy in critically ill cirrhotic patients	6
Primary hyperoxaluria: the adult nephrologist's point of view	6
Deep learning to classify arteriovenous access aneurysms in hemodialysis patients	6
COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?	6
Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population	6
Women's representation in clinical trials of patients with chronic kidney disease	6
Home dialysis in older adults: challenges and solutions	6
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy	6
Long-term exposure to air pollutants and increased risk of chronic kidney disease in a community-based population using a fuzzy logic inference model	6
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	6
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	6
The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysis	6
Subtyping hospitalized patients with hypokalemia by machine learning consensus clustering and associated mortality risks	6
Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	6
Management of hypertension in patients with cancer: challenges and considerations	6
The membrane perspective of uraemic toxins: which ones should, or can, be removed?	6